genomica - arraytech

What genomica - arraytech does

Arraytech Diagnostics SL is a Spain-based, privately held in vitro diagnostics (IVD) company founded in October 2023 in Alcobendas, Madrid, building on the legacy of Genomica SAU. The company develops, manufactures, and sells diagnostic kits, instruments, and consumables for clinical microbiology, molecular pathology, and cytology laboratories, with a secondary line of immunohistochemistry products marketed through its PathoSage subsidiary. Its core technology is the proprietary CLART (Clinical Array Technology) microarray platform, which enables simultaneous identification of multiple pathogens or biomarkers in a single sample; the CLART menu currently covers HPV (35 clinically relevant types), sexually transmitted infections, herpes/enterovirus, and respiratory viruses. Arraytech complements its kits with a closed instrument ecosystem including the CAR Reader for microarray interpretation, Autoclart and Autoclart Plus for workflow automation, the Genesya 96 real-time PCR system, the NanoReady Touch micro-volume spectrophotometer, and the EasySlide liquid-based cytology processor with dual membrane filtration.

The company operates a 200m2 ISO 13485-certified clean-room facility in Alcobendas staffed by a team with 15+ years of collective experience in microbiology and molecular pathology. Its go-to-market is direct sales to clinical, pathology, and cytology laboratories and healthcare professionals via the company website, contact form, and phone, with no public pricing and no disclosed distribution partners. The company claims a worldwide market reach through direct sales, with Europe as the primary operating region. Revenue model is a one-time hardware/kit sale plus recurring consumables across the CLART and EasySlide installed base, with no disclosed subscription, licensing, or service revenue streams. Revenue, headcount, funding, and named customers are not disclosed in the available material.

Name

genomica - arraytech

Legal name

Arraytech Diagnostics SL

Website

https://arraytech.es

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Arraytech Diagnostics SL is a Spain-based IVD company that manufactures CLART microarray-based diagnostic kits, automation instruments, and cytology/pathology consumables for clinical, pathology, and cytology laboratories worldwide.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLAAALAL

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAAALAC

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAAALAI

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLAHAAAD

Molecular Diagnostics (PCR/NAAT/NGS-based IVD)

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

• Molecular diagnostics
• Microarray diagnostic kits
• Clinical laboratory instruments
• Immunohistochemistry products
• Liquid-based cytology systems

Headquarters

HQ city

Alcobendas

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Diagnostic Kits: Sale of CLART diagnostic kits for molecular diagnostics including HPV, STDs, respiratory infections, and herpes/enterovirus detection.
2. Laboratory Instrumentation: Sale of specialized diagnostic instruments including CAR Reader, Autoclart, Autoclart Plus, Genesya 96 Real-Time PCR system, and NanoReady Touch spectrophotometer.
3. Cytology Consumables: Sale of cytology products including EasySlide LBC processor and related consumables (solutions, filters, slides).
4. Pathology Products: Sale of Pathosage branded IHC antibodies, detection kits, and consumables for pathology laboratories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Arraytech Diagnostics SL develops, manufactures, and supplies proprietary CLART microarray-based diagnostic kits (HPV, STDs, Entherpex, Fast Pneumovir) for simultaneous multi-pathogen detection, along with automated instruments (CAR Reader, Autoclart, Autoclart Plus, Genesya 96 real-time PCR, NanoReady Touch spectrophotometer), the EasySlide liquid-based cytology system with LBC consumables, and the PathoSage immunohistochemistry product line (antibodies, detection kits, consumables). The portfolio targets clinical, pathology, and cytology laboratories with in vitro diagnostic solutions for HPV, sexually transmitted infections, respiratory viruses, herpes/enterovirus, and IHC applications.

Product overview

Arraytech Diagnostics offers a comprehensive molecular diagnostics and pathology portfolio built around its proprietary CLART microarray technology. The product lineup includes four CLART diagnostic kits (HPV, STDs, Entherpex, and Fast Pneumovir) for pathogen detection, complemented by three CLART instruments (CAR Reader, Autoclart, and Autoclart Plus) for microarray analysis automation. The company also provides the Genesya 96 real-time PCR system and NanoReady Touch spectrophotometer for molecular research applications. In cytology, the EasySlide liquid-based system and consumables address sample preparation needs. Through its PathoSage subsidiary, Arraytech supplies IHC antibodies, detection kits, and pathology consumables. Together, these products form an integrated diagnostic ecosystem spanning molecular diagnostics, pathology, and cytology for clinical laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

• EasySlide LBC Processor Liquid-based cytology processor with dual membrane filtration technology for high-quality, consistent, and efficient sample preparation. Designed for clinical and cytology laboratories performing in vitro cytopathological examinations.
• LBC Consumables Consumables for liquid-based cytology processing, including solutions, filters, and slides used with the EasySlide processor.
• CLART HPV CLART microarray-based diagnostic kit that detects 35 clinically relevant types of human papillomavirus for in vitro diagnostic use. Intended for clinical laboratories performing HPV molecular diagnostics.
• CLART STDs CLART microarray-based diagnostic kit for genetic identification of pathogens responsible for sexually transmitted infections, providing rapid and accurate results for clinical laboratories.
• CLART Entherpex CLART microarray-based diagnostic kit for genotyping of herpes and enterovirus human infections using advanced in vitro genomic diagnostic technology.
• CLART Fast Pneumovir CLART microarray-based diagnostic kit that detects common respiratory viruses in human infections, providing rapid and reliable results for clinical laboratories.
• CAR Reader Advanced automated reader for interpretation of CLART microarrays with high precision in reading and quantifying signals, intuitive interface, and compatibility with all CLART microarrays.
• Autoclart Automation instrument that completes the microarray process from hybridization to result reading, minimizing human errors and ensuring consistency in data interpretation for clinical laboratories.
• Autoclart Plus Advanced post-PCR automation equipment that combines visualization and analysis to improve clinical laboratory efficiency in microarray-based workflows.
• NanoReady Touch Micro-volume UV-Vis spectrophotometer with a 7-inch color touch screen and Android OS, detection range 0.2-27,500 ng/uL dsDNA, for nucleic acid, protein, and bacterial culture concentration detection. Intended for research use.
• Genesya 96 96-well touchscreen quantitative fluorescence real-time PCR system with innovative thermal cycling and photoelectric detection, designed for research use in molecular diagnostics applications.
• Pathosage Primary Antibodies Primary antibodies for immunohistochemistry laboratories developed and supplied by Pathosage, an Arraytech company, for pathology laboratories, research laboratories, and immunology specialists.
• Pathosage Detection Kits Detection kits for immunohistochemistry applications supplied by Pathosage, an Arraytech company, for pathology laboratories and related diagnostic settings.
• Pathosage Consumables & Ancillaries Microscope slides, IHC pens, microtome blades, and general reagents for pathology laboratories, supplied by Pathosage, an Arraytech company.

Quantifiable outcome

• Detects 35 clinically relevant HPV types
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• PathoSagecoreOthersPathoSage is an Arraytech company that develops, manufactures, and supplies immunohistochemistry products to healthcare industry including IHC laboratories, research laboratories, and immunology specialists. Delivers high-quality goods and services to businesses, hospitals, laboratories, universities, and government institutions in Spain and worldwide.

Scale indicators5 records

Recent moves13 records

Expansion highlights8 records

Direct peers

• Hologic: Hologic's Diagnostics segment is a global leader in molecular HPV testing (Aptima), STI testing, and cytology (ThinPrep), directly overlapping Arraytech's CLART HPV/STDs kits and EasySlide cytology processor. Both target clinical and hospital laboratories with IVD kits and instrumentation.
• bioMérieux: bioMérieux is a major microbiology and infectious disease diagnostics company (BioBall, VIDAS, BIOFIRE FilmArray panels), competing directly with Arraytech's CLART microbiology kits for respiratory, STI, and enterovirus detection in hospital labs.
• Seegene: Seegene develops multiplex molecular diagnostic assays using proprietary technologies (TOCE, DPO) for simultaneous detection of multiple pathogens — closely analogous to Arraytech's CLART microarray multiplexing approach across HPV, STI, and respiratory panels.
• DiaSorin: DiaSorin is an Italian-headquartered IVD company with molecular diagnostics (LIAISON MDX) for infectious diseases and specialty immunodiagnostics, making it a comparable European mid-sized IVD player to Arraytech.
• ELITech Group: ELITech is a European IVD company offering molecular diagnostics kits (HPV, STI, respiratory) and instrumentation to clinical laboratories, with a comparable size and geographic footprint to Arraytech.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is a global IVD incumbent with broad portfolios in molecular diagnostics (cobas), HPV/sexually transmitted infection testing, and tissue diagnostics (Ventana). It is the dominant reference-lab and hospital supplier across Arraytech's product categories.
• Cepheid (Danaher): Cepheid's GeneXpert system sets the standard for rapid molecular PCR testing across infectious disease areas (HPV, STIs, respiratory viruses), directly competing with CLART in the molecular menu space Arraytech serves.
• Qiagen: Qiagen provides sample-prep and PCR-based molecular diagnostics (QIAstat-Dx, NeuMoDx) for infectious disease, positioning it as both a supplier of multiplex IVD technology and a competitor in respiratory and STI panels.
• QuidelOrtho: QuidelOrtho offers a broad IVD menu including molecular infectious disease testing (Savanna), Sofia rapid antigen tests, and specialty immunoassays — overlapping with Arraytech's respiratory virus, STI, and cytology offerings through a much larger commercial scale.
• Leica Biosystems (Danaher): Leica Biosystems is a major pathology/IHC solutions provider (BOND-III, antibodies, reagents), comparable to Arraytech's Pathosage subsidiary in selling primary antibodies, detection kits, and consumables to pathology laboratories.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/arraytech-diagnostics-sl

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about genomica - arraytech